2nd International Symposium on Triglycerides and HDL: lipid abnormalities and their treatment.
Bloomgarden
Zachary T
ZT
Division of Endocrinology, Mount Sinai School of Medicine, New York, NY, USA.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000097:blood*; D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000627:therapeutic use; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D019821:Simvastatin / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood*
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011804:Quinolines; D014280:Triglycerides; D009525:Niacin; C483909:torcetrapib; D019821:Simvastatin; D015248:Gemfibrozil